医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
24期
37-38
,共2页
詹平%代娟%范凌晔%毛熙光
詹平%代娟%範凌曄%毛熙光
첨평%대연%범릉엽%모희광
宫颈癌%RhoA%CD34%微血管密度%肿瘤转移
宮頸癌%RhoA%CD34%微血管密度%腫瘤轉移
궁경암%RhoA%CD34%미혈관밀도%종류전이
Cervical cancer%RhoA%CD34%Microvessel density%Neoplasm metastasis
目的:探讨RhoA及微血管密度(MVD)与宫颈癌发生发展的关系。方法采用免疫组织化学SP法,分别测定16例正常宫颈组织、20例宫颈上皮内瘤变组织、50例宫颈鳞癌组织中RhoA蛋白及CD34的表达。结果①宫颈鳞癌组RhoA的阳性表达与宫颈上皮内瘤变组和正常宫颈组比较有明显差异(<0.001;<0.001)。②宫颈鳞癌组MVD值与宫颈上皮内瘤变组和正常宫颈组比较有明显差异(<0.001;<0.001)。③Ⅱ期宫颈鳞癌RhoA和MVD的阳性表达分别与I期比较,差异有统计学意义(<0.05)。组织学分级G3 RhoA和MVD的阳性表达分别与G1RhoA和MVD比较有明显差异(<0.05)。宫颈鳞癌淋巴结转移组RhoA的阳性表达与无淋巴结转移组比较,无明显差异(>0.05),MVD比较也无差异(>0.05)。<35岁的年轻宫颈癌患者中RhoA的阳性表达率与≥35岁的宫颈癌患者比较,差异有统计学意义(<0.001)。两组患者MVD值比较,差异无统计学意义(>0.05)。结论在宫颈癌发生发展中,RhoA的表达增强和MVD增高可能发挥了重要作用。
目的:探討RhoA及微血管密度(MVD)與宮頸癌髮生髮展的關繫。方法採用免疫組織化學SP法,分彆測定16例正常宮頸組織、20例宮頸上皮內瘤變組織、50例宮頸鱗癌組織中RhoA蛋白及CD34的錶達。結果①宮頸鱗癌組RhoA的暘性錶達與宮頸上皮內瘤變組和正常宮頸組比較有明顯差異(<0.001;<0.001)。②宮頸鱗癌組MVD值與宮頸上皮內瘤變組和正常宮頸組比較有明顯差異(<0.001;<0.001)。③Ⅱ期宮頸鱗癌RhoA和MVD的暘性錶達分彆與I期比較,差異有統計學意義(<0.05)。組織學分級G3 RhoA和MVD的暘性錶達分彆與G1RhoA和MVD比較有明顯差異(<0.05)。宮頸鱗癌淋巴結轉移組RhoA的暘性錶達與無淋巴結轉移組比較,無明顯差異(>0.05),MVD比較也無差異(>0.05)。<35歲的年輕宮頸癌患者中RhoA的暘性錶達率與≥35歲的宮頸癌患者比較,差異有統計學意義(<0.001)。兩組患者MVD值比較,差異無統計學意義(>0.05)。結論在宮頸癌髮生髮展中,RhoA的錶達增彊和MVD增高可能髮揮瞭重要作用。
목적:탐토RhoA급미혈관밀도(MVD)여궁경암발생발전적관계。방법채용면역조직화학SP법,분별측정16례정상궁경조직、20례궁경상피내류변조직、50례궁경린암조직중RhoA단백급CD34적표체。결과①궁경린암조RhoA적양성표체여궁경상피내류변조화정상궁경조비교유명현차이(<0.001;<0.001)。②궁경린암조MVD치여궁경상피내류변조화정상궁경조비교유명현차이(<0.001;<0.001)。③Ⅱ기궁경린암RhoA화MVD적양성표체분별여I기비교,차이유통계학의의(<0.05)。조직학분급G3 RhoA화MVD적양성표체분별여G1RhoA화MVD비교유명현차이(<0.05)。궁경린암림파결전이조RhoA적양성표체여무림파결전이조비교,무명현차이(>0.05),MVD비교야무차이(>0.05)。<35세적년경궁경암환자중RhoA적양성표체솔여≥35세적궁경암환자비교,차이유통계학의의(<0.001)。량조환자MVD치비교,차이무통계학의의(>0.05)。결론재궁경암발생발전중,RhoA적표체증강화MVD증고가능발휘료중요작용。
Objective To estimate the expressions of RhoA and microvessel density (MVD)in squamous carcinoma of the cervix (SCC), cervical intraepithelial neoplasia (CIN) and normal cervical epithelium (NCE) and evaluate the possible mechanism in the invasion of cervical carcinoma. Methods In 16 NCE cases,20 CIN cases and 50 SCC cases,immunohistochemical S-P method had been used to examine the expression levels of RhoA and CD34. Results ①The expression level of RhoA was significantly higher in SCC than in CIN and NCE ( <0.001, <0.001). ② The MVD was significantly higher in SCC than in CIN and NCE ( <0.001, <0.001). ③ In comparison to stageⅠSCC, the expression levels of RhoA and MVD in stageIIwere significant difference ( <0.01;<0.01). In comparison to G1 SCC, the MVD and the expression levels of RhoA in G3 had significant dif erence ( <0.05;<0.001). In comparison to the without lymph nodal metastasis group, the expression levels of RhoA and MVD in SCC with lymph node metastasis group was no significantly different ( >0.05;>0.05). The expression levels of RhoA in more than 35 years old was higher than in less than 35 years old, there was significant dif erence( <0.001), but MVD was no significantly different in the two groups( >0.05). Conculusion RhoA might be a key role in the invasion and metastasis of squamous carcinoma of the cervix. The increase of microvessel density is closely related to the progression of tumor. Their levels maybe act as clinical referential indexes in the progression of cervical carcinoma.